SCHENK, DALE B.,NIJJAR, TARLOCHAN S.,PAYNE, PHILIP W.,BARBOUR, ROBIN
申请号：
CA2825791
公开号：
CA2825791A1
申请日:
2012.02.07
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The present invention provides antibodies that preferentially bind to an ApoE(1-272) fragment relative to ApoE(1-299). These antibodies serve to reduce the toxicity of this fragment and find use in treatment and prophylaxis of a variety of neurological diseases.
